Race modifies the association between adiposity and inflammation in patients with chronic kidney disease: Findings from the chronic renal insufficiency cohort study

Obesity

Volumn 22, Issue 5, 2014, Pages 1359-1366

  Wing, Maria R ^a   Yang, Wei ^b   Teal, Valerie ^b   Navaneethan, Sankar ^c   Tao, Kaixiang ^b   Ojo, Akinlolu ^d   Guzman, Nicolas N ^a   Reilly, Muredach ^e   Wolman, Melanie ^b   Rosas, Sylvia E ^f   Cuevas, Magda ^e   Fischer, Michael ^g   Lustigova, Eva ^h   Master, Stephen R ^e   Xie, Dawei ^b   Appleby, Dina ^b   Joffe, Marshall ^b,e   Kusek, John ⁱ   Feldman, Harold I ^f   Raj, Dominic S ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g JESSE BROWN VA MEDICAL CENTER   (United States)

^h TULANE UNIVERSITY   (United States)

ⁱ NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYSTATIN C; FIBRINOGEN; HEMOGLOBIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; SERUM ALBUMIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; IL1RN PROTEIN, HUMAN;

ADULT; AFRICAN AMERICAN; ANALYTIC METHOD; ARTICLE; BIOELECTRIC IMPEDANCE ANALYSIS; BODY FAT; BODY MASS; CAUCASIAN; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FAT FREE MASS; FAT MASS; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HISPANIC; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; OBESITY; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; SEX DIFFERENCE; WAIST CIRCUMFERENCE; AGED; BLOOD; CROSS-SECTIONAL STUDY; ETHNOLOGY; IMPEDANCE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; SOCIOECONOMICS; STATISTICAL MODEL;

ADIPOSITY; ADULT; AFRICAN AMERICANS; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ELECTRIC IMPEDANCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FIBRINOGEN; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-10; INTERLEUKIN-1BETA; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; SERUM ALBUMIN; SOCIOECONOMIC FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899913366     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20692     Document Type: Article

References (35)

1. Gupta J, Mitra N, Kanetsky PA, et al. Association between albuminuria, kidney function, and inflammatory biomarker profile. Clin J Am Soc Nephrol 2012; 7: 1938-1946.
2. Gregor MF, Hotamisligil GS,. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011; 29: 415-445.
3. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O,. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702.
4. Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 2006; 17: 1453-1459.
5. Mak RH, Cheung W,. Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens 2007; 16: 27-31.
6. Kimmel PL, Phillips TM, Phillips E, Bosch JP,. Effect of renal replacement therapy on cellular cytokine production in patients with renal disease. Kidney Int 1990; 38: 129-135.
7. Raj DSC, Dominic EA, Pai A, et al. Skeletal muscle, cytokines and oxidative stress in End-stage renal disease. Kidney Int 2005; 68: 2338-2344.
8. Raj DS, Shah H, Shah VO, et al. Markers of inflammation, proteolysis, and apoptosis in ESRD. Am J Kidney Dis 2003; 42: 1212-1220.
9. Cheung WW, Paik KH, Mak RH,. Inflammation and cachexia in chronic kidney disease. Pediatr Nephrol 2010; 25: 711-724.
10. Raj DS, Moseley P, Dominic EA, et al. Interleukin-6 modulates hepatic and muscle protein synthesis during hemodialysis. Kidney Int 2008; 73: 1054-1061.
11. Fried SK, Bunkin DA, Greenberg AS,. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83: 847-850.
12. Feldman HI, Appel LJ, Chertow GM, et al. The Chronic Renal Insufficiency Cohort (CRIC) study: design and methods. J Am Soc Nephrol 2003; 14: S148-S153.
13. Anderson AH, Yang W, Hsu CY, et al. Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis 2012; 60: 250-261.
14. Bellizzi V, Scalfi L, Terracciano V, et al. Early changes in bioelectrical estimates of body composition in chronic kidney disease. J Am Soc Nephrol 2006; 17: 1481-1487.
15. Janssen I, Heymsfield SB, Baumgartner RN, Ross R,. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000; 89: 465-471.
16. Garg AX, Blake PG, Clark WF, Clase CM, Haynes RB, Moist LM,. Association between renal insufficiency and malnutrition in older adults: results from the NHANES III Kidney Int 2001; 60: 1867-1874.
17. Chertow GM, Lowrie EG, Wilmore DW, et al. Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol 1995; 6: 75-81.
18. National Institute of Health. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults. Bethesda, MD: NIH; 1998.
19. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D,. Predictors of new-onset kidney disease in a community-based population. J Am Med Assoc 2004; 291: 844-850.
20. Muntner P, Winston J, Uribarri J, Mann D, Fox CS,. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med 2008; 121: 341-348.
21. World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. 2000. Report No.: World Health Organ Tech Rep Ser 894.
22. Balakrishnan VS, Jaber BL, Natov SN, et al. Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells in hemodialysis patients. Kidney Int 1998; 54: 2106-2112.
23. Roubenoff R,. Applications of bioelectrical impedance analysis for body composition to epidemiologic studies. Am J Clin Nutr 1996; 64: 459S-462S.
24. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
25. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW,. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-2282.
26. Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M, Munoz-Canoves P,. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 2008; 7: 33-44.
27. Boivin MA, Battah SI, Dominic EA, et al. Activation of caspase-3 in the skeletal muscle during haemodialysis. Eur J Clin Invest 2010; 40: 903-910.
28. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW, Jr,. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105.
29. Lovejoy JC, de la Bretonne JA, Klemperer M, Tulley R,. Abdominal fat distribution and metabolic risk factors: effects of race. Metabolism 1996; 45: 1119-1124.
30. Carroll JF, Chiapa AL, Rodriquez M, et al. Visceral fat, waist circumference, and BMI: impact of race/ethnicity. Obesity 2008; 16: 600-607.
31. Maury E, Brichard SM,. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010; 314: 1-16.
32. Hull HR, Thornton J, Wang J, et al. Fat-free mass index: changes and race/ethnic differences in adulthood. Int J Obes 2011; 35: 121-127.
33. Nascimento MM, Pecoits-Filho R, Qureshi AR, et al. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nephrol Dial Transplant 2004; 19: 2803-2809.
34. Kushner RF, Gudivaka R, Schoeller DA,. Clinical characteristics influencing bioelectrical impedance analysis measurements. Am J Clin Nutr 1996; 64: 423S-427S.
35. Beasley LE, Koster A, Newman AB, et al. Inflammation and race and gender differences in computerized tomography-measured adipose depots. Obesity 2009; 17: 1062-1069. Kidney Diseases Kidney Diseases Diseases Kidney Diseases Kidney Diseases Diseases Kidney Diseases Kidney Diseases